Leclerc Gabrielle, Lacasse Yves, Page Diane, Sériès Frédéric
Can Respir J. 2014 Jul-Aug;21(4):216-20. doi: 10.1155/2014/681952. Epub 2014 Apr 7.
Daytime somnolence is an important feature of the obstructive sleep apnea (OSA) hypopnea syndrome and is usually subjectively assessed using the Epworth Sleepiness Scale (ESS).
To compare the scores of the ESS and different domains of the Quebec Sleep Questionnaire (QSQ) assessed before and after the first months of continuous positive airway pressure (CPAP) treatment, as well as retrospectively without treatment.
The ESS score and domain scores of the QSQ were obtained before and after a three-month period of CPAP treatment using a retrospective assessment of the pretreatment scores in 76 untreated OSA patients.
Fifty-two patients completed the study. The ESS and QSQ scores significantly improved following CPAP therapy. Retrospective evaluation of the ESS score was significantly worse than pre- and post-treatment values (mean [± SD] pretreatment score 11.0±4.8; retrospective pretreatment score 13.5±5.1). Such differences were not observed in any domain of the QSQ, including the domain assessing hypersomnolence.
OSA patients underestimated their sleepiness according to the most widely used instrument to assess hypersomnolence. This finding may not be observed with other methods used to assess OSA-related symptoms such as quality of life questionnaires.
日间嗜睡是阻塞性睡眠呼吸暂停(OSA)低通气综合征的一个重要特征,通常使用爱泼沃斯嗜睡量表(ESS)进行主观评估。
比较在持续气道正压通气(CPAP)治疗的头几个月前后以及回顾性未治疗情况下,ESS得分与魁北克睡眠问卷(QSQ)不同领域的得分情况。
通过对76例未经治疗的OSA患者治疗前得分进行回顾性评估,获取CPAP治疗三个月前后的ESS得分和QSQ领域得分。
52例患者完成了研究。CPAP治疗后,ESS和QSQ得分显著改善。ESS得分的回顾性评估显著低于治疗前和治疗后的值(平均[±标准差]治疗前得分11.0±4.8;回顾性治疗前得分13.5±5.1)。在QSQ的任何领域,包括评估过度嗜睡的领域,均未观察到此类差异。
根据评估过度嗜睡最常用的工具,OSA患者低估了他们的嗜睡程度。使用其他评估OSA相关症状的方法,如生活质量问卷,可能不会出现这一发现。